Desikan Nithya 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Sep 1, 2020
Insider Transaction Report
Form 4
Desikan Nithya
Chief Commercial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-31−25,000→ 97,961 totalExercise: $6.88Exp: 2027-08-08→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2020-08-31$6.88/sh+25,000$172,000→ 68,602 total - Sale
Common Stock
2020-08-31$30.00/sh−25,000$750,000→ 43,602 total
Footnotes (2)
- [F1]On August 31, 2020, Ms. Desikan exercised and sold 25,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.